Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HER2 Positive Early Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05150652
What this trial is testing

Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer

Who this might be right for
Breast CancerHER2-negative Breast CancerNode-negative Breast Cancer+1 more
Irada Ibrahim-zada 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT05069038
What this trial is testing

Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy

Who this might be right for
Breast Cancer
University of Nebraska 51
Testing effectiveness (Phase 2)WithdrawnNCT04419181
What this trial is testing

Feasibility of Chemotherapy De-escalation in Early-Stage HER2 Positive Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
University of Rochester
Not applicableActive Not RecruitingNCT06782698
What this trial is testing

Home-Based Exercise Program During Neoadjuvant Treatment to Improve Fatigue and Quality of Life in Early HER2-Positive and Triple-Negative Breast Cancer Patients

Who this might be right for
Triple Negative Breast Cancer (TNBC)HER2-Positive Breast CancerEarly Breast Cancer+2 more
Centro Hospitalar Universitário de Santo António 50
Not applicableStudy completedNCT05599334
What this trial is testing

A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treated With Neratinib

Who this might be right for
Breast CancerAdjuvant TherapyHER2-positive Breast Cancer
Pierre Fabre Medicament 111
Testing effectiveness (Phase 2)Active Not RecruitingNCT06394661
What this trial is testing

Serplulimab Plus Chemotherapy for Early-stage HR+/HER2- Breast Cancer

Who this might be right for
Breast Cancer
Henan Cancer Hospital 109
Testing effectiveness (Phase 2)Looking for participantsNCT04553770
What this trial is testing

Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer

Who this might be right for
Early-stage Breast CancerHormone Receptor Positive Breast CarcinomaInvasive Breast Cancer+4 more
Jonsson Comprehensive Cancer Center 88
Large-scale testing (Phase 3)Looking for participantsNCT06492616
What this trial is testing

Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Who this might be right for
Breast Cancer
Stemline Therapeutics, Inc. 4,220
Testing effectiveness (Phase 2)Active Not RecruitingNCT05252988
What this trial is testing

Three Antidiarrheal Strategies in HER2+/HR+ Early Breast Cancer Patients Treated With Extended Adjuvant Neratinib

Who this might be right for
Early-stage Breast CancerHER2 Positive Breast CancerHormone Receptor Positive
Spanish Breast Cancer Research Group 177
Large-scale testing (Phase 3)UnknownNCT00712140
What this trial is testing

Trastuzumab in Treating Women With HER2-Positive Early Breast Cancer

Who this might be right for
Breast Cancer
Warwick Medical School 4,000
Testing effectiveness (Phase 2)Ended earlyNCT01928615
What this trial is testing

Subcutaneously Administered Herceptin (Trastuzumab) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 2
Large-scale testing (Phase 3)Study completedNCT01926886
What this trial is testing

Subcutaneous At Home Administration of Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2-positive (HER2+) Early Breast Cancer (eBC)

Who this might be right for
Breast Cancer
Hoffmann-La Roche 102
Large-scale testing (Phase 3)WithdrawnNCT06884254
What this trial is testing

Efficacy and Safety Study of EG1206A (EirGenix' Pertuzumab) Compared With EU-sourced Perjeta® (Pertuzumab) in Patients With HER2-positive Hormone Receptor Negative Early Breast Cancer.

Who this might be right for
Early Breast Cancer
EirGenix, Inc.
Large-scale testing (Phase 3)Not Yet RecruitingNCT07827573
What this trial is testing

Learn How Well Participants With a Specific Type of Early Breast Cancer (ER-Positive, HER2-Negative) Tolerate and Stay on Treatment With Giredestrant and How They Feel During Treatment

Who this might be right for
Early Breast CancerEstrogen Receptor-Positive Breast CancerHER2-Negative Breast Cancer
Hoffmann-La Roche 1,500
Large-scale testing (Phase 3)Active Not RecruitingNCT02513394
What this trial is testing

PALbociclib CoLlaborative Adjuvant Study

Who this might be right for
Breast Cancer
Alliance Foundation Trials, LLC. 5,796
Not applicableNot Yet RecruitingNCT07540520
What this trial is testing

A Real-World Study on the Impact of Different Adjuvant Treatment Regimens on Prognosis in Non-pCR Patients With HER2-Positive Breast Cancer After Neoadjuvant Therapy

Who this might be right for
Early Breast Cancer
Hebei Medical University Fourth Hospital 2,000
Testing effectiveness (Phase 2)Study completedNCT00493649
What this trial is testing

Adj TC + Herceptin Early Stage Breast Cancer

Who this might be right for
Breast Cancer
US Oncology Research 493
Not applicableEnded earlyNCT02771795
What this trial is testing

A Long-term Follow-up Study for Cardiac Safety in the Patients With HER2 (+) Breast Cancer Who Have Completed the SB3-G31-BC

Who this might be right for
Breast Neoplasms
Samsung Bioepis Co., Ltd. 538
Large-scale testing (Phase 3)Not Yet RecruitingNCT07294534
What this trial is testing

A Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX87in Combination With HLX22 or Pertuzumab in the Neoadjuvant Therapy of HER2-Positive Bresat Cancer

Who this might be right for
HER2 + Breast Cancer
Shanghai Henlius Biotech 817
Not applicableLooking for participantsNCT07218432
What this trial is testing

The TheraBionic P1 Device in Breast Cancer

Who this might be right for
Breast Cancer Stage IBreast Cancer Stage IIBreast Cancer Stage IIIA+2 more
Barbara Ann Karmanos Cancer Institute 24
Next Page